Medical Scientist Training Program (MSTP)

Medical Scientist Training Program

Featured Student

uploadedImages/education/mstp/featured-students/emily-miller.jpg

Emily Miller

The MSTP anatomy class is one of my favorite parts of the program. An excellent professor gives the lectures and the class is small, which is very conducive to asking questions and having discussions. Lab is like a personal tour of the human body. It is incredibly well organized, well executed, and very interesting.

 

The Medical Scientist Training Program (MSTP) at the Albert Einstein College of Medicine (Einstein) is one of the nation’s oldest. From the start, our goal has been to train a diverse group of outstanding students to become future leaders of academic medicine and medical research. Continuously funded by the National Institutes of Health since 1964, the Einstein MSTP has 448 illustrious Alumni with careers spanning the spectrum from basic science research to clinical medicine and many variations in between.

Today, the Einstein MSTP is still unique. Larger than most other MSTPs, it fosters a strong academic and social community within the college. While large enough to be an independent academic unit, the program is still small enough to provide students with the individual attention their unique careers require.

The current training program recognizes that the successful physician-scientist training is not simply medical school plus graduate training. The program integrates MSTP-specific courses with medical and graduate courses, during the first two years of preclinical course work. Integration continues in the PhD thesis years through weekly involvement in the MSTP Continuity Clinic and monthly Clinical Pathological Conferences and MSTP Career Paths seminars.

Students have outstanding publications and residency placements.

The Einstein MSTP encourages applications from all individuals. As stated in the College's Diversity and Inclusion Strategic Plan for Excellence, "At Einstein, we value all people and perspectives that make us unique and increase our diversity at large. Albert Einstein College of Medicine reaffirms its commitment to recruiting, retaining and advancing individuals from historically underrepresented and marginalized minority groups in the scientific and medical professions. At the College of Medicine, this includes, (in no particular order, and is not limited to) women, individuals who are black, Latino/Latina; Pacific Islander or indigenous Americans; individuals from new immigrant populations; individuals with both apparent and nonapparent disabilities; all sexual and gender minorities, including lesbian, gay, bisexual, asexual and queer people as well as transgender, gender-nonconforming and intersex individuals; religious minorities and individuals from economically disadvantaged backgrounds."

Awards & Accomplishments

  • Erik Hasenoehrl NIH NRSA F30 Fellowship for a project entitled "Targeting terminal respiratory oxidation in Mycobacterium tuberculosis: A novel investigation of Cytochrome bd oxidase function" (Co-Sponsors,  Michael Berney & William Jacobs, Microbiology & Immunology)
  • Joshua Mayoral NIH NRSA F31 Fellowship for a project entitled "Secreted effectors of Toxoplasma gondii bradyzoites" (Sponsor,  Louis Weiss, Pathology)
  • Joshua Weinreb NIH NRSA F30 Fellowship for a project entitled "Uncovering the Role of the DEAD Box Helicase Ddx41 in Hematopoiesis" (Sponsor,  Teresa Bowman, Developmental & Molecular Biology)
  • Rosiris Leon-Rivera NIH NRSA F31 Fellowship for a project entitled "Molecular Mechanisms of Increased Risk of Racial and Ethnic Minorities for HIV Associated Neurocognitive Disorders" (Sponsor,  Joan Berman, Pathology)
  • Todd Rubin NIH NRSA F31 Fellowship for a project entitled "Examining sex as a predictor of outcomes across multiple levels of head trauma" (Sponsor,  Michael Lipton, Neuroscience)
  • Niloy Iqbal NIH NRSA F30 Fellowship for a project entitled "Tumor Suppressor pRb is a Novel Target for Hypothalamic Inhibition of Diet Induced Obesity" (Sponsors,  Liang Zhu and Streamson Chua, Jr., Developmental & Molecular Biology)
  • Kristin Palarz NIH NRSA F31 Fellowship for a project entitled "Serotoninergic modulation of cerebellar circuitry" (Sponsor,  Kamran Khodakhah, Neuroscience)
  • Peter John NIH NRSA F30 Fellowship for a project entitled "B7x in Cancer: Mechanisms and Therapies" (Sponsor,  XingXing Zang, Microbiology & Immunology)
  • Richard Piszczatowski NIH NRSA F30 Fellowship for a project entitled "Investigating the role of Nol3 in normal and malignant hematopoiesis" (Sponsor,  Ulrich Steidl, Cell Biology)
  • Liane Hunter NIH NRSA F31 Fellowship for a project entitled "Identifying Biomarkers that Modify Outcomes in Soccer Heading" (Sponsor,  Michael Lipton, PhD in Clinical Investigation)
  • Justin Wheat NIH NRSA F30 Fellowship for a project entitled "Uncovering Transcriptional Regulation of a Master Hematopoietic Transcription Factor at Single Molecule Resolution" (Sponsor,  Ulrich Steidl & Robert Singer, Cell Biology and Anatomy & Structural Biology)
  • Jeet Biswas NIH NRSA F30 Fellowship for a project entitled "The sequence recognition, structure and function of the IMP family of mRNA binding proteins" (Sponsor,  Robert Singer, Anatomy & Structural Biology)
  • Ross Firestone NIH NRSA F30 Fellowship for a project entitled "Designing Novel Anti-Cancer Therapeutics: Targeting Methionine Metabolism" (Sponsor,  Vern Schramm, Biochemistry)
  • Ali Zahalka NIH NRSA F30 Fellowship for a project entitled "Contributions of sympathetic signals to prostate cancer progression" (Sponsor,  Paul Frenette, Cell Biology)
  • Sean Healton NIH NRSA F30 Fellowship for a project entitled "Epigenetic activity of normal and cancer-associated mutant H1 linker histones" (Sponsor,  Arthur Skolutchi, Cell Biology)
  • Cary Weiss NIH NRSA F30 Individual for a project entitled "MicroRNA-22 and the microRNA-22/tet2 network as regulators of the cell fate decision in hematopoietic stem cells and in the development of myelodysplastic syndrome" (Sponsor,  Keisuke Ito, Cell Biology)
  • Ruth Howe, NIH NRSA F30 Fellowship for a project entitled "Characterizing the Novel Protein C15ORF65" (Sponsor,  Ulrich Steidl, Cell Biology)
  • Marika Osterbur, NIH NRSA F30 Fellowship for a project entitled "Extra-coding features of mRNA are essential for hERG channel function" (Sponsor, Thomas McDonald, Molecular Pharmacology)
  • Karin Skalina, NIH NRSA F30 Fellowship for a project entitled "Optimization of non-ablative focused ultrasound therapy for tumor immunity" (Sponsor, Chandan Guha, Pathology)
  • Michael Willcockson, NIH NRSA F30 Fellowship for a project entitled "Regulators of the erythroid terminal differentiation decision and their connection to the cell cycle" (Sponsor, Art Skoultchi, Cell Biology)
  • Nelson Gil, NIH NRSA F31 Fellowship for a project entitled "The molecular basis of receptor-ligand recognition on the immunological synapse" (Sponsor, Andras Fiser, Systems & Computational Biology)
  • Kim Ohaegbulam, NIH NRSA F31 Fellowship for a project entitled "Tumor expressed B7x accelerates disease and is a novel target for immunotherapy" (Sponsor, Xingxing Zang, Microbiology & Immunology)
  • Jennifer Schloss, NIH NRSA F30 Fellowship for a project entitled "Use of beta cell epitopes in preventing type 1 diabetes in humanized mice" (Sponsor, Teresa DiLorenzo, Microbiology & Immunology)

 more awards 

Publications

  • publications Mike EV, Makinde HM, Der E, Stock A, Gulinello M, Gadhvi GT, Winter DR, Cuda CM, Putterman C. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling. Front Immunol. 2018 Sep 26.
  • publications Iqbal NJ, Lu Z, Liu SM, Schwartz GJ, Chua S Jr, Zhu L. Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity. JCI Insight. 2018 Sep 6.
  • publications Mike EV, Makinde HM, Gulinello M, Vanarsa K, Herlitz L, Gadhvi G, Winter DR, Mohan C, Hanly JG, Mok CC, Cuda CM, Putterman C. Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus. J Autoimmun. 2018 Aug 30.
  • publications Rubin TG*, Catenaccio E*, Fleysher R, Hunter LE, Lubin N, Stewart WF, Kim M, Lipton RB, Lipton ML. MRI-defined White Matter Microstructural Alteration Associated with Soccer Heading Is More Extensive in Women than Men. Radiology. . 2018 Jul 31. (*contributed equally)
  • publications Hunter LE, Ifrah C, Zimmerman ME, Kim M, Lipton RB, Stewart WF, Lipton ML. Heading and unintentional head impacts have opposing associations with Patient Reported Outcomes in amateur soccer players. Res Sports Med. 2018 Jul
  • publications Kaufman OH, Lee K, Martin M, Rothhämel S, Marlow FL. rbpms2 functions in Balbiani body architecture and ovary fate. PLoS Genet. 2018 Jul 5.
  • publications Gil N, Fiser A. The choice of sequence homologs included in multiple sequence alignments has a dramatic impact on evolutionary conservation analysis. Bioinformatics. 2018 Jun 27.
  • publications Bertalovitz AC*, Osterbur Badhey ML*, McDonald TV. Synonymous nucleotide modification of the KCNH2 gene affects both mRNA characteristics and translation of the encoded hERG ion channel. J Biol Chem. 2018 Jun 15. (*contributed equally).
  • publications Maryanovich M, Zahalka AH, Pierce H, Pinho S, Nakahara F, Asada N, Wei Q, Wang X, Ciero P, Xu J, Leftin A, Frenette PS. Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche. Nat Med. 2018 May 7.
  • publications Cabrera RM, Mao SPH, Surve CR, Condeelis JS, Segall JE. A novel neuregulin - jagged1 paracrine loop in breast cancer transendothelial migration. Breast Cancer Res. 2018 Apr 10
  • publications Schloss J, Ali R, Racine JJ, Chapman HD, Serreze DV, DiLorenzo TP. HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression. J Immunol. 2018 Apr 9.

more publications 

Click here to log in
Medical Scientist Training Program (MSTP)